Skip to content

"A clinical trial to study the role of advanced imaging modalities in evaluation of prostate cancer"

"Role of advanced ultrasound and advanced MRI in evaluation of prostate cancer"

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/03/018285
Enrollment
60
Registered
2019-03-26
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C61- Malignant neoplasm of prostate

Interventions

Intervention1: MRI guided biopsy of prostate and CEUS of prostate: MRI ingantry targeted biopsy and MRI-TRUS Fusion guided targeted biopsy of prostate and evaluation of CEUS in detection of prostate c

Sponsors

Departement of Radiodiagnosis AIIMS New Delhi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Adult Patient (age in completed years above 18) 2) PSA >5 ng/ml 3) Positive Digital rectal examination

Exclusion criteria

Exclusion criteria: 1) Histopathology other than adenocarcinoma. 2) MRI contraindications like pacemakers. 3) Contraindications for contrast administration like previous h/o reaction to Gadolinium, deranged renal function tests, etc. 4) Poor general condition/ performance status (e.g.- acute heart failure etc.) 5) Non consenting patients.

Design outcomes

Primary

MeasureTime frame
Prostate cancer detection rate comparison for MRI ingantry targeted biopsy and MRI-TRUS fusion targeted biopsies and CEUS-guided targeted biopsies compared with 12-core systematic biopsiesTimepoint: Cancer detection rate by biopsy within 1 week of MRI

Secondary

MeasureTime frame
To evaluate the value of using both mpMRI and CEUS in the detection of prostate cancer To study feasibility of IVIM in the detection of prostate cancerTimepoint: 6 weeks post biopsy (if biopsy already done)

Countries

India

Contacts

Public ContactArjunlokesh Netaji

AIIMS, New Delhi

dascj@yahoo.com8178939992

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026